{
  "id": "517a8ce98ed59a060a000045",
  "type": "summary",
  "question": "What is the treatment of acute pericarditis?",
  "ideal_answer": "A multidisciplinary approach is frequently necessary to treat acute pericarditis; the most frequent treatments are: antiinflammatory steroid and non-steroid drugs, antibiotic therapy, pericardial drainage and, less frequently ,intrapericardial irrigation of fibrinolytics;  antituberculous chemotherapy in presence of Tuberculous Agent",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18924029",
    "http://www.ncbi.nlm.nih.gov/pubmed/10560235",
    "http://www.ncbi.nlm.nih.gov/pubmed/12405580",
    "http://www.ncbi.nlm.nih.gov/pubmed/6726718",
    "http://www.ncbi.nlm.nih.gov/pubmed/12379412",
    "http://www.ncbi.nlm.nih.gov/pubmed/308705",
    "http://www.ncbi.nlm.nih.gov/pubmed/7375968",
    "http://www.ncbi.nlm.nih.gov/pubmed/6727432",
    "http://www.ncbi.nlm.nih.gov/pubmed/20074469",
    "http://www.ncbi.nlm.nih.gov/pubmed/10920507",
    "http://www.ncbi.nlm.nih.gov/pubmed/17180574",
    "http://www.ncbi.nlm.nih.gov/pubmed/17415329",
    "http://www.ncbi.nlm.nih.gov/pubmed/6966005"
  ],
  "snippets": [
    {
      "text": "Recurrences develop in up to 20-50% of patients with acute pericarditis. Although different causes of recurrent pericarditis have been identified, the etiology remains obscure in most cases which are therefore labelled as idiopathic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20074469",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "A poor response to colchicine treatment and/or a steroid-dependence may be the clue to investigate TNFRSF1A mutations in patients with idiopathic recurrent pericarditis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20074469",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "intravenous infusion of inotropic agents",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18924029",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "medical treatment may be changed in these patients with a slower tapering of the dosage of steroidal and non-steroidal antiinflammatory drugs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17180574",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The incidence of purulent pericarditis has decreased considerably since the antibiotic era. It is typically an acute and potentially lethal disease, necessitating rapid diagnosis and adequate therapy to improve prognosis. Standard treatment combines appropriate antibiotic therapy with surgical drainage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12405580",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "We report successful treatment of a non-resolving fibrino-purulent pericardial effusion by combined intrapericardial irrigation of fibrinolytics and systemic corticosteroids administration as an alternative to pericardectomy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12379412",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Prednisolone (20-30 mg/d) was used in addition to antituberculous chemotherapy in 11 of the 17 patients with effusive pericarditis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10560235",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "antibiotic therapy has been initiated. Use of appropriate parenterally administered antibiotics, in combination with early surgical pericardial drainage or partial pericardiectomy, should minimize morbidity and mortality and prevent acute constrictive sequelae.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6727432",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": []
}